D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 52 Citations 14,275 120 World Ranking 1864 National Ranking 772

Overview

What is she best known for?

The fields of study she is best known for:

  • Cancer
  • Immune system
  • Gene

Her primary scientific interests are in Radiation therapy, Immunotherapy, Immune system, Immunology and Abscopal effect. The study incorporates disciplines such as CTLA-4, Cancer research, Lung cancer and Antigen in addition to Radiation therapy. Her study looks at the relationship between Immunotherapy and topics such as Combined Modality Therapy, which overlap with Neoplasms therapy.

In her research, CD8 and Transforming growth factor beta is intimately related to Blockade, which falls under the overarching field of Immune system. Her work carried out in the field of Abscopal effect brings together such families of science as Dose fractionation, Ionizing radiation, Oncology and Pathology. Her Oncology research incorporates elements of Clinical trial, Carcinoma, Dosing, Biomarker and Breast cancer.

Her most cited work include:

  • The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 (1126 citations)
  • Fractionated but not single dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody (931 citations)
  • Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated (793 citations)

What are the main themes of her work throughout her whole career to date?

Sandra Demaria focuses on Cancer research, Immunotherapy, Immunology, Immune system and Radiation therapy. Her studies deal with areas such as Cancer cell, Blockade, CD8, Breast cancer and Antibody as well as Cancer research. Her Immunotherapy study incorporates themes from Tumor microenvironment, T cell and Cytotoxic T cell.

Her biological study deals with issues like Antigen, which deal with fields such as Molecular biology and Receptor. Her Radiation therapy research incorporates themes from Abscopal effect, Ipilimumab and Oncology. Sandra Demaria interconnects Biomarker, Clinical trial, Tumor-infiltrating lymphocytes and Triple-negative breast cancer in the investigation of issues within Oncology.

She most often published in these fields:

  • Cancer research (37.06%)
  • Immunotherapy (31.47%)
  • Immunology (31.12%)

What were the highlights of her more recent work (between 2018-2021)?

  • Immune system (30.42%)
  • Cancer research (37.06%)
  • Internal medicine (24.13%)

In recent papers she was focusing on the following fields of study:

Her primary areas of investigation include Immune system, Cancer research, Internal medicine, Oncology and Radiation therapy. The subject of her Immune system research is within the realm of Immunology. Her Cancer research research is multidisciplinary, relying on both Cancer cell, Cancer, Tumor microenvironment, CD8 and Cytotoxic T cell.

Her Oncology research is multidisciplinary, incorporating perspectives in Peripheral blood mononuclear cell and Personalized therapy. Her biological study spans a wide range of topics, including Adjuvant, Immunotherapy, MHC class I, Colorectal cancer and Effector. Sandra Demaria combines subjects such as Blockade, Adverse effect, MEDLINE and Intensive care medicine with her study of Immunotherapy.

Between 2018 and 2021, her most popular works were:

  • Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers (170 citations)
  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (106 citations)
  • Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system. (54 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Immune system
  • Gene

The scientist’s investigation covers issues in Internal medicine, Oncology, Breast cancer, Cancer and Cancer research. Her study in Breast cancer is interdisciplinary in nature, drawing from both Chemotherapy regimen, Stromal tumor and Cancer immunology. The Cancer research study combines topics in areas such as Immune checkpoint, Cancer cell, Immune system and Cytotoxic T cell, Antigen presentation.

Cancer cell connects with themes related to Abscopal effect in her study. Her Immune system research includes themes of Cancer treatment, Radiation therapy and Omics. Sandra Demaria works mostly in the field of Radiation therapy, limiting it down to topics relating to Myeloid-derived Suppressor Cell and, in certain cases, Immunotherapy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

R. Salgado;R. Salgado;C. Denkert;S. Demaria;N. Sirtaine.
Annals of Oncology (2015)

1424 Citations

Fractionated but not single dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

M. Zahidunnabi Dewan;Ashley E. Galloway;Noriko Kawashima;J. Keith Dewyngaert.
Clinical Cancer Research (2009)

1131 Citations

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

Sandra Demaria;Bruce Ng;Mary Louise Devitt;James S Babb.
International Journal of Radiation Oncology Biology Physics (2004)

965 Citations

Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

Sylvia Adams;Robert J. Gray;Sandra Demaria;Lori Goldstein.
Journal of Clinical Oncology (2014)

918 Citations

Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer

Sandra Demaria;Noriko Kawashima;Anne Marie Yang;Mary Louise Devitt.
Clinical Cancer Research (2005)

842 Citations

Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift

Silvia C. Formenti;Sandra Demaria.
Journal of the National Cancer Institute (2013)

781 Citations

Systemic effects of local radiotherapy

Silvia C Formenti;Sandra Demaria.
Lancet Oncology (2009)

766 Citations

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.

Claire Vanpouille-Box;Amandine Alard;Amandine Alard;Molykutty J. Aryankalayil;Yasmeen Sarfraz.
Nature Communications (2017)

644 Citations

An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer

Encouse B. Golden;Sandra Demaria;Peter B. Schiff;Abraham Chachoua.
Cancer immunology research (2013)

560 Citations

Consensus guidelines for the detection of immunogenic cell death

Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli.
OncoImmunology (2014)

545 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sandra Demaria

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 138

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 137

Sherene Loi

Sherene Loi

Peter MacCallum Cancer Centre

Publications: 74

Laurence Zitvogel

Laurence Zitvogel

Institut Gustave Roussy

Publications: 64

Giuseppe Curigliano

Giuseppe Curigliano

European Institute of Oncology

Publications: 61

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 60

Oliver Kepp

Oliver Kepp

Institut Gustave Roussy

Publications: 50

Silvia C. Formenti

Silvia C. Formenti

Cornell University

Publications: 49

Carsten Denkert

Carsten Denkert

Philipp University of Marburg

Publications: 42

Jérôme Galon

Jérôme Galon

Université Paris Cité

Publications: 41

Benjamin Frey

Benjamin Frey

University of Erlangen-Nuremberg

Publications: 40

Udo S. Gaipl

Udo S. Gaipl

University of Erlangen-Nuremberg

Publications: 37

Charles G. Drake

Charles G. Drake

Columbia University

Publications: 35

Paolo A. Ascierto

Paolo A. Ascierto

National Institutes of Health

Publications: 34

Radek Spisek

Radek Spisek

Sotio (Czechia)

Publications: 33

Ralph R. Weichselbaum

Ralph R. Weichselbaum

University of Chicago

Publications: 33

Trending Scientists

Patrice Genevet

Patrice Genevet

Centre national de la recherche scientifique, CNRS

Omer Oralkan

Omer Oralkan

North Carolina State University

Zygmunt Gryczynski

Zygmunt Gryczynski

Texas Christian University

Rafael Kandiyoti

Rafael Kandiyoti

Imperial College London

Katrin Böhning-Gaese

Katrin Böhning-Gaese

Goethe University Frankfurt

Allan Larson

Allan Larson

Washington University in St. Louis

Teresa M. Coque

Teresa M. Coque

Instituto Ramón y Cajal de Investigación Sanitaria

Pierre Henry

Pierre Henry

Aix-Marseille University

Pierre Testor

Pierre Testor

Sorbonne University

Darius Ceburnis

Darius Ceburnis

National University of Ireland, Galway

Karl G. Richards

Karl G. Richards

Teagasc - The Irish Agriculture and Food Development Authority

Etienne Koechlin

Etienne Koechlin

Inserm : Institut national de la santé et de la recherche médicale

Sam J. Gilbert

Sam J. Gilbert

University College London

Marcus Lira Brandão

Marcus Lira Brandão

Universidade de São Paulo

Graeme Jones

Graeme Jones

University of Tasmania

Jennifer Wolch

Jennifer Wolch

University of California, Berkeley

Something went wrong. Please try again later.